Unique ID issued by UMIN | UMIN000037314 |
---|---|
Receipt number | R000042416 |
Scientific Title | Evaluation study for influence of intake of RIW-1 on improvement in intestinal environment |
Date of disclosure of the study information | 2019/10/31 |
Last modified on | 2020/01/09 17:05:25 |
Evaluation study for influence of intake of RIW-1 on improvement in intestinal environment
Evaluation study for influence of intake of RIW-1 on improvement in intestinal environment
Evaluation study for influence of intake of RIW-1 on improvement in intestinal environment
Evaluation study for influence of intake of RIW-1 on improvement in intestinal environment
Japan |
Healthy adults
Adult |
Others
NO
To evaluate the efficacy of intake of supplements in improving intestinal environment
Efficacy
Intestinal bacterial flora
Stool composition
Questionnaire on defecation(distention, exhaust gas amount, defecation frequency, defecation pain, defecation quantity, defecation feeling, stool form, stool smell)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Daily intake of high-dose test food for 4 weeks
Daily intake of low-dose test food for 4 weeks
Daily intake of placebo food for 4 weeks
30 | years-old | <= |
49 | years-old | >= |
Female
1) Healthy Japanese females aged 30 to 49 years old
2) Subjects who have less habit of eating yogurt (2 times a week or less)
3) Subjects who have less habit of drinking lactic acid bacteria beverage (once a week or less)
4) Subjects who have no habit of taking in fiber-fortified foods, oligosaccharides or lactic acid bacteria Yeast supplements
5) Subjects with defecation frequency 4 to 8 times per week
6) Subjects with hard to normal form of stool (Bristol Stool Scale 2 to 4)
7) Subjects who do not alternate constipation and diarrhea
8) Subjects who can collect their own stool specimens and keep them in their own freezer at home until submission
9) Subjects who have periodic menstruation
10) Subjects with BMI less than 25
1) Subjects who participate in other clinical trials
2) Subjects who are pregnant, lactating or possibly pregnant
3) Subjects with menopause
4) Subjects with tendency of diarrhea or loose stool
5) Subjects who regularly use antiflatulents, stomach medicines, gastrointestinal drugs, laxatives or female hormones
99
1st name | Takashi |
Middle name | |
Last name | Koikeda |
Shiba Palace Clinic
Chair
105-0013
DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1590
jimukyoku@mail.souken-r.com
1st name | Miwa |
Middle name | |
Last name | Kaneko |
SOUKEN Co., Ltd
Management Division
105-0013
DaiwaA Hamamatsucho Bldg. 3F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1555
m_kaneko@mail.souken-r.com
Shiba Palace Clinic
Asahi Quality and Innovations, Ltd.
Self funding
Shiba Palace Clinic Ethics Review Committee
DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1599
shiba_palace@s-palace-clinic.com
NO
2019 | Year | 10 | Month | 31 | Day |
Unpublished
99
Completed
2019 | Year | 06 | Month | 26 | Day |
2019 | Year | 07 | Month | 11 | Day |
2019 | Year | 07 | Month | 18 | Day |
2019 | Year | 09 | Month | 26 | Day |
2019 | Year | 07 | Month | 09 | Day |
2020 | Year | 01 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042416
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |